Hoth Therapeutics Inc. (NASDAQ: HOTH)
$0.93
-0.0024 ( -0.26% ) 24.5K
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Market Data
Open
$0.93
Previous close
$0.93
Volume
24.5K
Market cap
$4.88M
Day range
$0.90 - $0.99
52 week range
$0.83 - $3.37
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 08, 2024 |
4 | Insider transactions | 1 | Jan 08, 2024 |
10-q | Quarterly Reports | 51 | Nov 13, 2023 |
8-k | 8K-related | 22 | Oct 05, 2023 |
8-k | 8K-related | 20 | Sep 15, 2023 |
8-k | 8K-related | 12 | Aug 21, 2023 |
8-k | 8K-related | 46 | Aug 17, 2023 |
10-q | Quarterly Reports | 52 | Aug 11, 2023 |
4 | Insider transactions | 1 | Jul 18, 2023 |
4 | Insider transactions | 1 | Jul 18, 2023 |